PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026BMC Anesthesiology0 citationsOpen Access

Anesthesia management in oncology patients undergoing irreversible electroporation outside the operating room: a case series

DSDuygu Ozdemir SimsekHacettepe University HospitalEÜEmre ÜnalBahçeşehir UniversitySDSehend DebbağHacettepe University

Key Points

  • The aim is to evaluate anesthesia management in oncology patients undergoing irreversible electroporation outside the operating room.
  • Retrospective case series of 12 oncology patients
  • General anesthesia applied with invasive arterial monitoring and ECG synchronization
  • Assessment of hemodynamic stability and postoperative complications
  • Hemodynamic stability maintained in all 12 cases
  • Transient cardiac events observed but no medical intervention necessary
  • Only one minor complication reported: corneal epithelial erosion

Abstract

Irreversible electroporation is a novel, non-thermal tumor ablation technique that induces cell death through electrical disruption of cellular membranes while preserving surrounding connective tissue structures. Despite its clinical advantages, the high-voltage pulses used during the procedure can provoke hemodynamic and electrophysiological instability, requiring specific anesthetic precautions. Data on anesthesia management during irreversible electroporation, particularly in non-operating room anesthesia, remain limited. This case series describes 12 oncology patients who underwent irreversible electroporation procedures under general anesthesia outside the operating room. Standard monitoring, invasive arterial pressure, and electrocardiographic synchronization were employed to prevent arrhythmias. Hemodynamic stability was preserved in all cases. Transient cardiac events—including bradycardia, ventricular extrasystoles, or mild hypertension—were observed but required no medical intervention. Postoperative pain control was satisfactory, and only one minor complication—corneal epithelial erosion—was reported. Biochemical analyses revealed slight changes, none of which were clinically relevant. Irreversible electroporation appears to be a feasible and potentially safe procedure when appropriate anesthetic precautions are applied. Deep neuromuscular blockade, electrocardiography synchronization, and readiness for arrhythmia management are essential for patient safety. Multidisciplinary coordination and postoperative follow-up further enhance procedural success. Not applicable. This study is a retrospective case series and does not require registration in a clinical trial. • IRE is a non-thermal tumor ablation technique that allows preservation of surrounding structures such as vessels and nerves. • Anesthesia management during IRE must address potential complications, including cardiac arrhythmias and muscle contractions. • This case series of twelve oncology patients highlights perioperative events encountered during IRE procedures outside the operating room. • ECG synchronization and deep neuromuscular blockade are important to prevent arrhythmogenic and neuromuscular complications. • Vigilant monitoring, multidisciplinary planning, and appropriate anesthetic precautions may contribute to the safe performance of IRE.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Simsek et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc3c1dee9eb8c0dce547ahttps://doi.org/10.1186/s12871-026-03971-0
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Electroporation of the heart2005 · 98 citations
  2. 2Anaesthetic management during open and percutaneous irreversible electroporation2014 · 104 citations
  3. 3Electrical reversion of cardiac arrhythmias.1967 · 667 citations
  4. 4Tissue Ablation with Irreversible Electroporation2005 · 1,276 citations
  5. 5Irreversible electroporation and electrochemotherapy in oncology: State of the art2022 · 88 citations